日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

miR-155 aberrant expression impairs tumor rejection because of its targeting of ICOSL and multiple pathways implicated in the antitumor response

miR-155的异常表达会损害肿瘤排斥,因为它靶向ICOSL以及参与抗肿瘤反应的多个通路。

Tili, Esmerina; Michaille, Jean-Jacques; Croce, Carlo M

What does BCL-2 do? From new molecular insights to the clinical implications

BCL-2 有什么作用?从新的分子机制到临床意义

Croce, Carlo M; Tait, Stephen W G; Garcia-Sáez, Ana J; Villunger, Andreas; Letai, Anthony; Walter, Harriet S; Dyer, Martin J S; Green, Douglas R; Shi, Yufang; Melino, Gerry

Targeting metabolic vulnerabilities: REV-ERB agonist SR9009 potentiates sorafenib efficacy in liver cancer.

靶向代谢脆弱性:REV-ERB 激动剂 SR9009 可增强索拉非尼在肝癌中的疗效。

Sabbioni Silvia, Guerriero Paola, Shankaraiah Ram C, Masatti Laura, Michilli Angelo, Bassi Cristian, D'Abundo Lucilla, Moshiri Farzaneh, De Siena Bruno, Simoni Edi, Astolfi Laura, Gramantieri Laura, Roncarati Roberta, Elamin Bahaeldin K, Bonora Massimo, Pinton Paolo, Croce Carlo M, Negrini Massimo, Callegari Elisa

Nasopharyngeal carcinoma: a model cancer to understand tumor rejection

鼻咽癌:一种用于理解肿瘤排斥反应的癌症模型

Nuovo, Gerard J; Tili, Esmerina; Croce, Carlo M

The BCL-2 protein family: from discovery to drug development

BCL-2蛋白家族:从发现到药物研发

Croce, Carlo M; Vaux, David; Strasser, Andreas; Opferman, Joseph T; Czabotar, Peter E; Fesik, Stephen W

Acute degradation of nucleolin reveals its novel functions in cell cycle progression and cell division in triple negative breast cancer.

核仁素的急性降解揭示了其在三阴性乳腺癌细胞周期进程和细胞分裂中的新功能

Mills Joseph, Tessari Anna, Anastas Vollter, Sunilkumar Damu, Samadi Rad Nastaran, Lamba Saranya, Cosentini Ilaria, Reers Ashley, Zhu Zirui, Miles Wayne O, Coppola Vincenzo, Cocucci Emanuele, Magliery Thomas J, Shive Heather, Davies Alexander E, Rizzotto Lara, Croce Carlo M, Palmieri Dario

miR-155 impairs ICOSL and MHC-I expression in DLBCL lymphomas.

miR-155 会损害 DLBCL 淋巴瘤中 ICOSL 和 MHC-I 的表达

Tili Esmerina, Commisso Teresa L, Balatti Veronica, Michaille Jean-Jacques, Nuovo Gerard J, Croce Carlo M

Comprehensive view on chemotherapy-free management of acute myeloid leukemia by using venetoclax in combination with targeted and/or immune therapies

全面探讨使用维奈托克联合靶向和/或免疫疗法治疗急性髓系白血病的无化疗方案

Kegyes, David; Tat, Andrei; Vizitiu, Alin Stefan; Vazar-Tripon, Daiana; Ilie, Radu; Tigu, Adrian Bogdan; Cenariu, Diana; Bancos, Anamaria; Iluta, Sabina; Jitaru, Ciprian; Nistor, Madalina; Tomai, Radu; Gulei, Diana; Zdrenghea, Mihnea; Einsele, Hermann; Ghiaur, Gabriel; Croce, Carlo M; Tomuleasa, Ciprian

Loss of ICOSL expression in the progression to cervical carcinoma

ICOSL表达缺失与宫颈癌的进展

Nuovo, Gerard J; Tili, Esmerina; Croce, Carlo M

Poly(A)-specific RNase (PARN) generates and regulates miR-125a-5p 3'-isoforms, displaying an altered expression in breast cancer

Poly(A)特异性核糖核酸酶(PARN)生成并调控miR-125a-5p 3'-亚型,这些亚型在乳腺癌中表达发生改变。

Tomasello, Luisa; Holub, Shoshanah M; Nigita, Giovanni; Distefano, Rosario; Croce, Carlo M